Envista (NYSE:NVST) Given New $17.00 Price Target at Piper Sandler

Envista (NYSE:NVST - Get Free Report) had its price objective hoisted by Piper Sandler from $16.00 to $17.00 in a report issued on Thursday, Benzinga reports. The firm presently has a "neutral" rating on the stock. Piper Sandler's price target points to a potential downside of 18.93% from the stock's current price.

Other research analysts also recently issued research reports about the stock. Leerink Partners raised shares of Envista from an "underperform" rating to a "market perform" rating and lifted their price objective for the company from $16.00 to $23.00 in a research report on Thursday. Needham & Company LLC reissued a "hold" rating on shares of Envista in a research report on Thursday. Evercore ISI lifted their price objective on shares of Envista from $18.00 to $23.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. Bank of America decreased their price objective on shares of Envista from $22.00 to $19.00 and set a "buy" rating for the company in a research report on Thursday, August 8th. Finally, JPMorgan Chase & Co. downgraded shares of Envista from an "overweight" rating to a "neutral" rating and decreased their price objective for the company from $23.00 to $16.00 in a research report on Thursday, August 8th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Envista has a consensus rating of "Hold" and an average target price of $20.71.

Envista Stock Up 9.0 %

Envista stock traded up $1.74 during mid-day trading on Thursday, reaching $20.97. The company's stock had a trading volume of 6,325,138 shares, compared to its average volume of 2,433,710. The company has a market capitalization of $3.61 billion, a price-to-earnings ratio of -2.72 and a beta of 1.32. Envista has a 12 month low of $15.15 and a 12 month high of $25.64. The business's 50 day simple moving average is $18.60 and its 200 day simple moving average is $18.06. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.90 and a current ratio of 2.22.

Envista (NYSE:NVST - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.03. Envista had a negative net margin of 52.25% and a positive return on equity of 4.86%. The business had revenue of $601.00 million during the quarter, compared to the consensus estimate of $590.34 million. During the same quarter last year, the firm earned $0.43 earnings per share. The firm's revenue for the quarter was down 4.8% compared to the same quarter last year. As a group, research analysts anticipate that Envista will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In other Envista news, CFO Eric D. Hammes acquired 24,532 shares of the company's stock in a transaction on Monday, August 12th. The stock was acquired at an average price of $16.33 per share, for a total transaction of $400,607.56. Following the purchase, the chief financial officer now directly owns 24,532 shares of the company's stock, valued at $400,607.56. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company's stock.

Hedge Funds Weigh In On Envista

Hedge funds and other institutional investors have recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Envista in the 3rd quarter valued at approximately $31,000. GAMMA Investing LLC raised its position in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock valued at $35,000 after buying an additional 726 shares in the last quarter. Blue Trust Inc. raised its position in shares of Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock valued at $39,000 after buying an additional 804 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock valued at $43,000 after buying an additional 728 shares in the last quarter. Finally, Versant Capital Management Inc raised its position in shares of Envista by 1,420.3% in the 2nd quarter. Versant Capital Management Inc now owns 3,147 shares of the company's stock valued at $52,000 after buying an additional 2,940 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.